Health

Clinical Trial Raises Hopes That Malaria Drug Could Be Coronavirus Cure

THOMAS SAMSON/AFP via Getty Images

Daily Caller News Foundation logo
Chuck Ross Investigative Reporter
Font Size:
  • A drug used to treat malaria is showing promise in lab and clinical studies for coronavirus, leading to reserved enthusiasm for some scientists. 
  • French researchers found that hydroxychloroquine lowered virus levels in most patients who took part in a clinical study this month.
  • President Donald Trump asked his coronavirus task force about the drug during a briefing on Wednesday. 

The results of a clinical trial in France and studies conducted in lab settings are building hope that a drug usually used to treat malaria and arthritis can treat and possibly cure coronavirus patients, though scientists say more data is needed before drawing a firm conclusion.

“It has a lot of potential, though we’re not going on a lot of data yet,” Dr. Peter Hotez, the dean for the National School of Tropical Medicine at the Baylor School of Medicine, said of early studies of hydroxycholoroquine, a malaria drug developed in the 1940s.

President Donald Trump asked the White House’s coronavirus task force about possibly using the drug, task force coordinator Dr. Deborah Birx said Wednesday.

Birx said that the drug is being studied “very carefully,” as are several other potential therapeutics.

On Tuesday, a team of French scientists released the first results of a clinical study of the use of hydroxychloroquine on 24 coronavirus patients from southeast France.

The research team, led by Didier Raoult, a renowned infectious disease expert from l’Institut Hospitalo-Universitaire in Marseille, administered the drug for 10 days along with azithromycin, a common antibiotic.

Researchers said the drugs cleared the virus in the nose and throat of most observed patients in three to six days. The study found that after six days of treatment, 70 percent of patients administered hydroxychloroquine were clear of the virus, compared to just 12.5 percent of patients who were not given drugs. (RELATED: Fauci On Coronavirus In US: ‘It’s Going To Get Worse’)

Azithromycin boosted the effect of hydroxychloroquine, according to the study. After six days of treatment, all patients treated with the drug combination “were virologically cured,” compared to 57.1 percent of patients treated with hydroxycholorquine by itself.

“We therefore recommend that COVID-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of COVID-19 in the world,” wrote researchers, who acknowledged the small sample size of the study.

Vice President Mike Pence and the White House coronavirus task force (Drew Angerer/Getty Images)

Lab studies have shown that hydroxychloroquine, which was developed in the 1940s, inhibited coronavirus. A study published in Cell Discovery on Wednesday by three Chinese scientists found that hydroxychloroquine inhibited coronavirus in vitro, or in a lab culture.

Hotez, the infectious disease expert, told The Daily Caller News Foundation he was “enthusiastic” about early results of studies involving hydroxychloroquine, though he said more data is needed to determine if the drug can effectively treat coronavirus.

“We urgently need to accelerate new antimicrobial therapies. If hydroxychloroquine could be approved in therapy it would be a game-changer,” Hotez said.

“The important next step is to show that it has an impact on reducing severity of symptoms in clinical disease.”

Hotez said that an ideal study would be conducted in areas with high rates of transmission, such as the Lombardy region in Italy.

More clinical trials are underway. A researcher at Asan Medical Center, a top research hospital in South Korea, is conducting a clinical trial of 150 patients with mild cases of coronavirus. The lead researcher, Sung-Han Kim, estimates that the trial will be completed in May.

According to NBC News, French drug maker Sanofi is working with health authorities to study whether hydroxychloroquine can help with coronavirus. The company is encouraged by preliminary findings, according to NBC News, but still does not have enough data to determine its efficacy.

Health officials in Belgium and South Korea have recommended the use of hydroxychloroquine patients displaying either severe or mild symptoms from COVID-19, the disease caused by coronavirus.

The United Kingdom appears to have some hope for the drug. On Sunday, government officials there banned the export and hoarding of hydroxychloroquine and two other drugs that could be useful as therapeutics, according to Pharmaceutical Technology.

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.

PREMIUM ARTICLE: Subscribe To Keep Reading

Sign up

By subscribing you agree to our Terms of Use

You're signed up!

Sign up

By subscribing you agree to our Terms of Use

You're signed up!
Sign up

By subscribing you agree to our Terms of Use

You're signed up!

Sign up

By subscribing you agree to our Terms of Use

You're signed up!
Sign up

By subscribing you agree to our Terms of Use

You're signed up!

Sign Up

By subscribing you agree to our Terms of Use

You're signed up!
Sign up

By subscribing you agree to our Terms of Use

You're signed up!
Sign up

By subscribing you agree to our Terms of Use

You're signed up!
BENEFITS READERS PASS PATRIOTS FOUNDERS
Daily and Breaking Newsletters
Daily Caller Shows
Ad Free Experience
Exclusive Articles
Custom Newsletters
Editor Daily Rundown
Behind The Scenes Coverage
Award Winning Documentaries
Patriot War Room
Patriot Live Chat
Exclusive Events
Gold Membership Card
Tucker Mug

What does Founders Club include?

Tucker Mug and Membership Card
Founders

Readers,

Instead of sucking up to the political and corporate powers that dominate America, The Daily Caller is fighting for you — our readers. We humbly ask you to consider joining us in this fight.

Now that millions of readers are rejecting the increasingly biased and even corrupt corporate media and joining us daily, there are powerful forces lined up to stop us: the old guard of the news media hopes to marginalize us; the big corporate ad agencies want to deprive us of revenue and put us out of business; senators threaten to have our reporters arrested for asking simple questions; the big tech platforms want to limit our ability to communicate with you; and the political party establishments feel threatened by our independence.

We don't complain -- we can't stand complainers -- but we do call it how we see it. We have a fight on our hands, and it's intense. We need your help to smash through the big tech, big media and big government blockade.

We're the insurgent outsiders for a reason: our deep-dive investigations hold the powerful to account. Our original videos undermine their narratives on a daily basis. Even our insistence on having fun infuriates them -- because we won’t bend the knee to political correctness.

One reason we stand apart is because we are not afraid to say we love America. We love her with every fiber of our being, and we think she's worth saving from today’s craziness.

Help us save her.

A second reason we stand out is the sheer number of honest responsible reporters we have helped train. We have trained so many solid reporters that they now hold prominent positions at publications across the political spectrum. Hear a rare reasonable voice at a place like CNN? There’s a good chance they were trained at Daily Caller. Same goes for the numerous Daily Caller alumni dominating the news coverage at outlets such as Fox News, Newsmax, Daily Wire and many others.

Simply put, America needs solid reporters fighting to tell the truth or we will never have honest elections or a fair system. We are working tirelessly to make that happen and we are making a difference.

Since 2010, The Daily Caller has grown immensely. We're in the halls of Congress. We're in the Oval Office. And we're in up to 20 million homes every single month. That's 20 million Americans like you who are impossible to ignore.

We can overcome the forces lined up against all of us. This is an important mission but we can’t do it unless you — the everyday Americans forgotten by the establishment — have our back.

Please consider becoming a Daily Caller Patriot today, and help us keep doing work that holds politicians, corporations and other leaders accountable. Help us thumb our noses at political correctness. Help us train a new generation of news reporters who will actually tell the truth. And help us remind Americans everywhere that there are millions of us who remain clear-eyed about our country's greatness.

In return for membership, Daily Caller Patriots will be able to read The Daily Caller without any of the ads that we have long used to support our mission. We know the ads drive you crazy. They drive us crazy too. But we need revenue to keep the fight going. If you join us, we will cut out the ads for you and put every Lincoln-headed cent we earn into amplifying our voice, training even more solid reporters, and giving you the ad-free experience and lightning fast website you deserve.

Patriots will also be eligible for Patriots Only content, newsletters, chats and live events with our reporters and editors. It's simple: welcome us into your lives, and we'll welcome you into ours.

We can save America together.

Become a Daily Caller Patriot today.

Signature

Neil Patel